- Research works
- 2 fractional, all time
- Citations
- 13 7.7 per fractional work
- Top-10% rate
- 30.6% record average 16.5%
- Open access
- 21% world 28%
Not ranked overall: Biomica (Israel) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Which research topics does Biomica (Israel) publish most on?
By volume in 2022–2025: Cancer Research and Treatments, Cancer Immunotherapy and Biomarkers, Pancreatic and Hepatic Oncology Research and Inflammatory Bowel Disease.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Cancer Research and Treatments Biotechnology 0 works
- 2 Cancer Immunotherapy and Biomarkers Oncology 0 works
- 3 Pancreatic and Hepatic Oncology Research Oncology 0 works
- 4 Inflammatory Bowel Disease Genetics 0 works
- 5 Microscopic Colitis Epidemiology 0 works
- 6 Gut microbiota and health Molecular Biology 0 works
- 7 Health and Medical Research Impacts Public Health, Environmental and Occupational Health 0 works
- 8 Biosimilars and Bioanalytical Methods Immunology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Biomica (Israel)'s research output changed?
Other research institutions in Rehovot
- Weizmann Institute of Science
- Kaplan Medical Center
- Biokine (Israel)
- Nova Measuring Instruments (Israel)
- Melodea (Israel)
- Yeda Research and Development (Israel)
- Elfi-Tech (Israel)
- Vyne Therapeutics (Israel)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.